Basic Information
| LncRNA/CircRNA Name | POTEF-AS1 |
| Synonyms | LOC105373617 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | Microarray, qPCR, RNAi, Cell proliferation assay etc. |
| Sample | prostate cancer tissues, cell lines (LNCaP and VCaP) |
| Expression Pattern | up-regulated |
| Function Description | POTEF-AS1 expression is significantly higher in prostate cancer compared to benign prostate hyperplasia. POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells. |
| Pubmed ID | 28032932 |
| Year | 2017 |
| Title | Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells. |
External Links
| Links for POTEF-AS1 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |